Jørgen Bjerggaard Jensen
Clinical trials sponsored by Jørgen Bjerggaard Jensen, explained in plain language.
-
Blood test triggers early cancer fight in groundbreaking trial
Disease control OngoingThis study is testing if starting immunotherapy earlier can better control metastatic bladder cancer. It involves 154 adults who have had their bladder removed for cancer. Doctors use a sensitive blood test to detect tiny signs of cancer return and then immediately start the immu…
Phase: PHASE2 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Shorter treatment time may ease bladder cancer therapy side effects
Symptom relief OngoingThis study is testing if reducing the amount of time a standard bladder cancer treatment (BCG) stays in the bladder can make side effects less severe. It involves 314 patients with high-risk non-muscle invasive bladder cancer across Nordic countries. The goal is to help more pati…
Phase: PHASE4 • Sponsor: Jørgen Bjerggaard Jensen • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC